Articles

Results 6 to 10 of 49
Most popular |Most recent


Life Sciences Company Settles Regulation FD Charges with SEC

USA - September 4 2019 On August 20, 2019, the US Securities and Exchange Commission (SEC) charged TherapeuticsMD Inc., a Boca Raton, Florida, headquartered life sciences…

Eric Orsic, Gary Emmanuel, Mark S. Selinger.

Capital Markets & Public Companies Quarterly 6

USA - July 19 2019 During the previous quarter, the SEC proposed new rulemaking to reduce the number of smaller companies that become subject to enhanced reporting…

Daniel L. Woodard, Eric Orsic, Gary Emmanuel, Heidi Steele, Mark J. Mihanovic, Robert H. Cohen, Thomas J. Murphy, William Hadler.

Capital Markets & Public Companies Quarterly

USA - April 15 2019 On March 20, 2019, the US Securities and Exchange Commission (SEC) adopted amendments that simplify and update certain disclosure requirements…

Gary Emmanuel, Mark J. Mihanovic, Robert H. Cohen, Thomas J. Murphy, William Hadler.

SEC Adopts Modernization and Simplification of Regulation S-K

USA - April 15 2019 On March 20, 2019, the US Securities and Exchange Commission (SEC) adopted amendments that simplify and update certain disclosure requirements…

Daniel L. Woodard, Eric Orsic.

Come on In, the Water’s Fine: SEC Proposes Expanding “Test-the-Waters” Communications to All Issuers

USA - March 4 2019 On February 19, 2019, the SEC proposed a new rule, Rule 163B, that would allow all issuers to engage in "test-the-waters" communications prior to the…

Daniel L. Woodard, Eric Orsic, Hank Goldberg.